All News
Links:
Pain is the Focus of the 2021 Nobel Prize in Medicine
The 2021 Nobel Prize in Medicine and Physiology was jointly awarded to Drs.
Read ArticleLinks:
Links:
Can tender and swollen joint counts work in a telemedicine world?
In a world where telemedicine and virtual care are not going away, is there value in patients assessing their own tender and swollen joints?
Read ArticleJanet Pope Janetbirdope ( View Tweet)
Links:
David Liew drdavidliew ( View Tweet)
David Liew drdavidliew ( View Tweet)
Richard Conway RichardPAConway ( View Tweet)
Large GWAS Study Reveals Genetic Basis for Osteoarthritis Phenotypes
Cell has published the results of a multinational, GWAS meta-analyses of 826,690 individuals that included 177,517 osteoarthritis patients, finding 52 previously unknown osteoarthritis (OA) genetic risk variants and linking OA genetic risks with joint distribution and pain
Read ArticleRheumNow Podcast – Like Father, Like Daughter (10.29.2021)
Bad things happen when our patients go into the ICU and it's not always due to the disease. Good things happen when we rise from sitting. And guess what? Rheumatologists are setting cardiology straight about hydroxychloroquine and chloroquine. This, and a special recognition of parent-child rheumatologists, along with the news and articles from this week on RheumNow.
Read ArticlePlatelet-Rich Plasma Injections Fail in Ankle Osteoarthritis
A controlled trial of intra-articular platelet-rich plasma (PRP) injections into the ankle of osteoarthritis (OA) patients failed to improve ankle symptoms and function when compared to placebo injections - yet another trial showing that intraarticular injections are seldom beneficial.
Read ArticlePfizer/Lilly Pull Tanezumab Development
Today, Lilly and Pfizer announced their global clinical development of the NGF inhibitor, tanezumab, has been discontinued due to recent negative opinions from the EMA and FDA advisory committee.
Read ArticleLinks:
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast – Rheumatologist Smoke-Enders (10.22.2021)
Today I have a few questions: Is tramadol really a weak narcotic? Should we really still be doing placebo-controlled trials? What are we going to do about our patients who are smokers? This and more, in this week's review of the news and journal articles.
Read ArticleLinks: